Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Enoxaparin | 11 | 2007 | 391 | 0.860 |
Why?
|
| Heparin | 8 | 2007 | 1636 | 0.480 |
Why?
|
| Coronary Disease | 7 | 2007 | 5919 | 0.420 |
Why?
|
| Fibrinolytic Agents | 9 | 2007 | 2080 | 0.420 |
Why?
|
| Thrombolytic Therapy | 6 | 2007 | 2055 | 0.360 |
Why?
|
| Heparin, Low-Molecular-Weight | 4 | 2003 | 344 | 0.300 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 4 | 2003 | 577 | 0.290 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2007 | 169 | 0.280 |
Why?
|
| Blood Pressure Determination | 2 | 2021 | 646 | 0.270 |
Why?
|
| Angina Pectoris | 3 | 2004 | 957 | 0.230 |
Why?
|
| Counterpulsation | 1 | 2002 | 16 | 0.210 |
Why?
|
| Tyrosine | 3 | 2003 | 1427 | 0.200 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2002 | 223 | 0.180 |
Why?
|
| Cardiac Output | 1 | 2002 | 838 | 0.170 |
Why?
|
| Angina, Unstable | 6 | 2004 | 893 | 0.170 |
Why?
|
| Anticoagulants | 6 | 2003 | 4850 | 0.140 |
Why?
|
| Shock, Cardiogenic | 1 | 2002 | 711 | 0.140 |
Why?
|
| Catheterization | 1 | 2002 | 1431 | 0.140 |
Why?
|
| Myocardial Infarction | 10 | 2007 | 11521 | 0.130 |
Why?
|
| Hypogonadism | 1 | 2021 | 805 | 0.120 |
Why?
|
| Electrocardiography | 3 | 2002 | 6413 | 0.120 |
Why?
|
| Angioplasty, Balloon, Coronary | 4 | 2007 | 1724 | 0.110 |
Why?
|
| Acute Disease | 5 | 2007 | 7245 | 0.110 |
Why?
|
| Ambulatory Care Facilities | 1 | 2020 | 941 | 0.110 |
Why?
|
| Patient Discharge | 2 | 2024 | 3491 | 0.110 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2003 | 2763 | 0.110 |
Why?
|
| Hemorrhage | 4 | 2004 | 3466 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 3 | 2017 | 7460 | 0.100 |
Why?
|
| Myocardial Ischemia | 1 | 2002 | 2139 | 0.090 |
Why?
|
| Aspirin | 1 | 2002 | 3135 | 0.090 |
Why?
|
| Hypertension | 2 | 2021 | 8617 | 0.090 |
Why?
|
| Testosterone | 1 | 2021 | 2493 | 0.090 |
Why?
|
| Mammography | 1 | 2020 | 2434 | 0.080 |
Why?
|
| Drug Therapy, Combination | 5 | 2007 | 6320 | 0.070 |
Why?
|
| Primary Health Care | 1 | 2024 | 4748 | 0.070 |
Why?
|
| Antithrombins | 1 | 2007 | 294 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2020 | 8544 | 0.060 |
Why?
|
| Double-Blind Method | 5 | 2007 | 12467 | 0.050 |
Why?
|
| Blood Substitutes | 1 | 2002 | 57 | 0.050 |
Why?
|
| Syndrome | 3 | 2003 | 3274 | 0.050 |
Why?
|
| Myocardial Reperfusion | 1 | 2002 | 339 | 0.050 |
Why?
|
| Myocardial Revascularization | 2 | 2002 | 796 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2017 | 3838 | 0.040 |
Why?
|
| Middle Aged | 13 | 2024 | 223737 | 0.040 |
Why?
|
| Treatment Outcome | 8 | 2007 | 65480 | 0.040 |
Why?
|
| Humans | 24 | 2024 | 768970 | 0.040 |
Why?
|
| Male | 15 | 2024 | 365203 | 0.040 |
Why?
|
| Aged | 10 | 2024 | 171786 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 2002 | 680 | 0.040 |
Why?
|
| Female | 15 | 2024 | 397515 | 0.040 |
Why?
|
| Aftercare | 1 | 2024 | 921 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2002 | 2231 | 0.040 |
Why?
|
| Erythrocyte Transfusion | 1 | 2002 | 575 | 0.040 |
Why?
|
| Office Visits | 1 | 2021 | 596 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2002 | 1737 | 0.030 |
Why?
|
| Teaching Rounds | 1 | 2021 | 282 | 0.030 |
Why?
|
| Continuity of Patient Care | 1 | 2024 | 1076 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 2002 | 2932 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2002 | 2664 | 0.030 |
Why?
|
| Cause of Death | 2 | 2004 | 3721 | 0.030 |
Why?
|
| Acute Coronary Syndrome | 1 | 2007 | 2194 | 0.030 |
Why?
|
| Equipment Design | 1 | 2002 | 3530 | 0.030 |
Why?
|
| Recurrence | 2 | 2007 | 8513 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 21188 | 0.030 |
Why?
|
| Hospitalization | 2 | 2024 | 10847 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2002 | 9684 | 0.030 |
Why?
|
| Adult | 6 | 2024 | 223851 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 2003 | 2100 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2002 | 4199 | 0.020 |
Why?
|
| Logistic Models | 2 | 2003 | 13318 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2020 | 2008 | 0.020 |
Why?
|
| Secondary Prevention | 2 | 2007 | 1476 | 0.020 |
Why?
|
| Length of Stay | 1 | 2002 | 6526 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2002 | 54962 | 0.020 |
Why?
|
| Boston | 1 | 2020 | 9377 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2002 | 3683 | 0.020 |
Why?
|
| United States | 2 | 2007 | 73186 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2017 | 2241 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 3238 | 0.020 |
Why?
|
| Registries | 1 | 2002 | 8384 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 4056 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2017 | 2192 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2024 | 39394 | 0.020 |
Why?
|
| Mass Screening | 1 | 2020 | 5457 | 0.010 |
Why?
|
| Time Factors | 2 | 2021 | 40261 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2024 | 7957 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2007 | 10400 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2017 | 3269 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 15471 | 0.010 |
Why?
|
| Communication | 1 | 2017 | 3908 | 0.010 |
Why?
|
| Prevalence | 1 | 2020 | 15879 | 0.010 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2003 | 446 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 20245 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2024 | 41808 | 0.010 |
Why?
|
| Obesity | 1 | 2003 | 13091 | 0.010 |
Why?
|
| Combined Modality Therapy | 2 | 2002 | 8559 | 0.010 |
Why?
|
| New York | 1 | 2002 | 884 | 0.010 |
Why?
|
| Endpoint Determination | 1 | 2002 | 594 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2007 | 3554 | 0.010 |
Why?
|
| Meta-Analysis as Topic | 1 | 2003 | 1364 | 0.010 |
Why?
|
| Risk Factors | 2 | 2002 | 74976 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2024 | 81903 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2002 | 59739 | 0.010 |
Why?
|
| Cattle | 1 | 2002 | 3819 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2002 | 1531 | 0.010 |
Why?
|
| Anemia | 1 | 2002 | 1517 | 0.010 |
Why?
|
| Peptides | 1 | 2003 | 4353 | 0.010 |
Why?
|
| Postoperative Complications | 2 | 2002 | 15889 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2003 | 9264 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2002 | 15951 | 0.000 |
Why?
|
| Incidence | 1 | 2002 | 21547 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2002 | 24333 | 0.000 |
Why?
|
| Animals | 1 | 2002 | 169335 | 0.000 |
Why?
|
Concepts
(113)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(24)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_